SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-20-001600
Filing Date
2020-02-14
Accepted
2020-02-14 13:01:40
Documents
2
Period of Report
2020-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3968
2 ex24_nichols.htm EX-24 9130
  Complete submission text file 0001179110-20-001600.txt   14539
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Issuer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQUARE, BLDG 1400E CAMBRIDGE MA 02139
Business Address
Nichols Andrew John (Reporting) CIK: 0001683749 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 20617151